Tilray Brands (TSX:TLRY) Research & Development: C$0 Mil (TTM As of Feb. 2026)


TSX:TLRY Tilray Brands Inc TSX:TLRY
59 GF Score
Price C$6.34
GF Value C$17.50
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Tilray Brands Research & Development?

Tilray Brands TSX:TLRY -3.65% 59 Research & Development is C$0 Mil as of Feb. 2026. GuruFocus rates TSX:TLRY with a GF Score™ of 59/100 and a GF Value™ of C$17.50 (Possible Value Trap). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Tilray Brands's Research & Development for the three months ended in Feb. 2026 was C$0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Feb. 2026 was C$0 Mil.

Tilray Brands  (TSX:TLRY) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Tilray Brands Research & Development Related Terms

Tilray Brands Research & Development Historical Data

* Premium members only.

The historical data trend for Tilray Brands's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tilray Brands Research & Development Chart

Tilray Brands Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.01 1.95 0.92 0.87 0.39

Tilray Brands Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.05 0.06 0.11 0.09
TSX:TLRY
59GF Score
Tilray Brands Inc TSX:TLRY
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tilray Brands Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of C$0 Mil mean?
Tilray Brands (TSX:TLRY) has a Research & Development of C$0 Mil as of Feb. 2026. Research and development expense is the total cost for research and development activities. View historical data on Tilray Brands and its competitors.
Is Tilray Brands' Research & Development too high?
Tilray Brands' current Research & Development is C$0 Mil. Overall, Tilray Brands has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Tilray Brands' Research & Development compare to IRWD and BIOA?
Tilray Brands' Research & Development of C$0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Tilray Brands and its competitors. Tilray Brands's current Research & Development is C$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tilray Brands stock overvalued right now?
Based on GuruFocus' analysis, Tilray Brands (TSX:TLRY) is currently considered Possible Value Trap. The stock's GF Value™ is C$17.50, compared to a current price of C$6.34 — trading 63.8% below its estimated fair value. The current Research & Development is C$0 Mil. Tilray Brands' overall GF Score™ is 59/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Tilray Brands (TSX:TLRY), the current Research & Development is C$0 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tilray Brands (TSX:TLRY) Overvalued in 2026?

Based on GuruFocus' analysis, Tilray Brands stock appears to be undervalued. The current stock price of C$6.34 is trading 63.8% below its estimated GF Value™ of C$17.50. GuruFocus considers Tilray Brands to be Possible Value Trap.

Key valuation signals for TSX:TLRY:

  • Research & Development: C$0 Mil
  • GF Value™: C$17.50 vs. price of C$6.34 (63.8% below fair value)
  • GF Score™: 59/100 with 5 warning signs

No single metric tells the full story. See the TSX:TLRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tilray Brands Business Description

Address 265 Talbot Street West, Leamington, ON, CAN, N8H 5L4
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
59GF Score

Get the complete analysis for TSX:TLRY

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$6.34
Price
C$17.50
GF Value